WallStreetZenWallStreetZen

NASDAQ: TELO
Telomir Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TELO

Based on 1 analyst offering 12 month price targets for Telomir Pharmaceuticals Inc

Min Forecast
$4.00+257.14%
Avg Forecast
$4.00+257.14%
Max Forecast
$4.00+257.14%

Should I buy or sell TELO stock?

Based on 1 analyst offering ratings for Telomir Pharmaceuticals Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TELO stock forecasts and price targets.

TELO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-17

1 of 1

Forecast return on equity

Is TELO forecast to generate an efficient return?

Company
-390.23%
Industry
-25.91%
Market
145.99%
TELO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TELO forecast to generate an efficient return on assets?

Company
-366.05%
Industry
-17.12%
TELO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TELO earnings per share forecast

What is TELO's earnings per share in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.29

TELO revenue forecast

What is TELO's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$1.5M

TELO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TELO$1.12$4.00+257.14%Strong Buy
GANX$1.78$6.50+265.17%Strong Buy
BSEM$4.36N/AN/A
PMVP$1.46$5.00+242.47%Buy
RNXT$1.73$8.75+405.78%Buy
View Top Biotech Stocks

Telomir Pharmaceuticals Stock Forecast FAQ

Is Telomir Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: TELO) stock is to Strong Buy TELO stock.

Out of 1 analyst, 1 (100%) are recommending TELO as a Strong Buy, 0 (0%) are recommending TELO as a Buy, 0 (0%) are recommending TELO as a Hold, 0 (0%) are recommending TELO as a Sell, and 0 (0%) are recommending TELO as a Strong Sell.

If you're new to stock investing, here's how to buy Telomir Pharmaceuticals stock.

What is TELO's earnings growth forecast for 2026-2026?

(NASDAQ: TELO) Telomir Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Telomir Pharmaceuticals's earnings in 2026 is -$51,989,865.

In 2026, TELO is forecast to generate -$19,642,127 in earnings, with the lowest earnings forecast at -$18,871,848 and the highest earnings forecast at -$20,219,837.

What is TELO's revenue growth forecast for 2026-2026?

(NASDAQ: TELO) Telomir Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Telomir Pharmaceuticals's revenue in 2026 is $0.

In 2026, TELO is forecast to generate $105,225,683 in revenue, with the lowest revenue forecast at $101,099,185 and the highest revenue forecast at $108,320,556.

What is TELO's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: TELO) forecast ROA is -366.05%, which is lower than the forecast US Biotechnology industry average of -17.12%.

What is TELO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year TELO price target, the average TELO price target is $4.00, with the highest TELO stock price forecast at $4.00 and the lowest TELO stock price forecast at $4.00.

The Wall Street analyst predicted that Telomir Pharmaceuticals's share price could reach $4.00 by Sep 17, 2027. The average Telomir Pharmaceuticals stock price prediction forecasts a potential upside of 257.14% from the current TELO share price of $1.12.

What is TELO's Earnings Per Share (EPS) forecast for 2026-2026?

(NASDAQ: TELO) Telomir Pharmaceuticals's current Earnings Per Share (EPS) is -$0.91. In 2026, TELO's EPS is forecast to hit -$0.29 (min: -$0.27, max: -$0.29).

What is TELO's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: TELO) forecast ROE is -390.23%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.